ALLENA PHARMACEUTICALS INC - COM (ALNAQ)

CUSIP: 018119107

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
16,661,058
Share change
+15,516
Total reported value
$90,774,131
Price per share
$5.45
Number of holders
49
Value change
-$325,148
Number of buys
22
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 018119107?
CUSIP 018119107 identifies ALNAQ - ALLENA PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ALLENA PHARMACEUTICALS INC - COM (ALNAQ) as of Q4 2018

As of 31 Dec 2018, ALLENA PHARMACEUTICALS INC - COM (ALNAQ) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,661,058 shares. The largest 10 holders included FRAZIER MANAGEMENT LLC, TRV GP II, LLC, Deer VII & Co. Ltd., MORGAN STANLEY, Partner Fund Management, L.P., FMR LLC, BlackRock Inc., Vanguard Group Inc, SPHERA FUNDS MANAGEMENT LTD., and ADAGE CAPITAL PARTNERS GP, L.L.C.. This page lists 49 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.